Wednesday, February 15, 2023
3:00 PM – 4:00 PM (EST)

 

Add to Calendar

No registration is required to participate - the Series is free and open to anyone. To participate, log in with your ASCO.org username and password. Create a new, free account or for assistance with your existing login.

Charles A. Schiffer, MD, FASCO
Wayne State University School of Medicine
Welcome and Introduction

Marlise Rachael Luskin, MD
Dana-Farber Cancer Institute
State of the Science: Ph+ALL

Elias Jabbour, MD
University of Texas MD Anderson Cancer Center
Abstract 398868: First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). 

Anjali S. Advani, MD
Cleveland Clinic Foundation
Discussion of Abstract 398868 - Are we Ready for a Change in Practice? (US Perspective) 

Nicolas Boissel, MD, PhD 
Hôpital Saint-Louis
Discussion of Abstract 398868 - Are we Ready for a Change in Practice? (European Perspective) 

Panel Question and Answer with Drs. Jabbour, Luskin, Advani, and Boissel, moderated by Dr. Schiffer